Methods of administering elagolix | Patent Publication Number 20180235963

US 20180235963 A1

Patent NumberUS 10537572 B2

Application Number15957469

Filled DateApr 19, 2018

Priority DateSep 1, 2015

Publication DateAug 23, 2018

Original AssigneeAbbvie Inc.

Current AssigneeAbbvie Inc.

Inventor/ApplicantsSandra L. Goss
Juki Wing-Keung Ng
Cheri E. Klein
Ahmed Salem

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.